A Study of ATI-50002 Topical Solution for the Treatment of Alopecia Areata
Status:
Terminated
Trial end date:
2019-09-10
Target enrollment:
Participant gender:
Summary
Primary:
• To assess safety, tolerability and efficacy of 2 dose strengths of ATI-50002 Topical
Solution, compared to vehicle in subjects with alopecia areata (AA)
Secondary:
• To evaluate key clinical outcome assessments